Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Leapman, Michael
Presley, Carolyn J.
Zhu, Weiwei
Soulos, Pamela R.
Adelson, Kerin B.
Boffa, Daniel J.
Gross, Cary Philip
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Yale Univ, New Haven, CT USA
[4] Yale Sch Med, Thorac Surg Sect, Dept Surg, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9059
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Recommendations
    Gagne, Andreanne
    Wang, Emily
    Bastien, Nathalie
    Orain, Michele
    Desmeules, Patrice
    Page, Sylvain
    Trahan, Sylvain
    Couture, Christian
    Joubert, David
    Joubert, Philippe
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : 2062 - 2070
  • [42] Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S319 - S319
  • [43] PD-L1 Expression and Survival among Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy
    Sorensen, Steffen Filskov
    Zhou, Wei
    Dolled-Filhart, Marisa
    Georgsen, Jeanette Baehr
    Wang, Zhen
    Emancipator, Kenneth
    Wu, Dianna
    Busch-Sorensen, Michael
    Meldgaard, Peter
    Hager, Henrik
    TRANSLATIONAL ONCOLOGY, 2016, 9 (01): : 64 - 69
  • [44] Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
    Lin, Shu-Yung
    Yang, Ching-Yao
    Liao, Bin-Chi
    Ho, Chao-Chi
    Liao, Wei-Yu
    Chen, Kuan-Yu
    Tsai, Tzu-Hsiu
    Hsu, Chia-Lin
    Hsu, Wei-Hsun
    Su, Kang-Yi
    Chang, Yih-Leong
    Lee, Jih-Hsiang
    Lin, Chia-Chi
    Shih, Jin-Yuan
    Yang, James Chih-Hsin
    Yu, Chong-Jen
    JOURNAL OF CANCER, 2018, 9 (10): : 1813 - 1820
  • [45] PD-L1 heterogeneity in patients with non-small cell lung cancer
    Wei, Zhigang
    Fan, Linlin
    Yang, Xia
    Li, Jie
    Zhan, Xuemei
    Ye, Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E268 - E274
  • [46] PD-L1 immunohistochemistry in patients with non-small cell lung cancer
    Jotatsu, Takanobu
    Oda, Keishi
    Yatera, Kazuhiro
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2127 - S2129
  • [47] Advanced non-small cell lung cancer: the role of PD-L1 inhibitors
    Heigener, David F.
    Reck, Martin
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1468 - S1473
  • [48] A REAL-WORLD ANALYSIS OF TREATMENT PATTERNS FOR FIRST-LINE IMMUNOTHERAPIES AMONG DANISH PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) AND PD-L1 EXPRESSION $50%
    Clugston, D. M.
    Beck, C.
    Bjerregaard, B. K.
    Kristensen, E. S.
    VALUE IN HEALTH, 2023, 26 (12) : S514 - S514
  • [49] Challenges of PD-L1 testing in non-small cell lung cancer and beyond
    Wang, Minyu
    Wang, Sen
    Trapani, Joseph A.
    Neeson, Paul J.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4541 - 4548
  • [50] Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer
    Gelatti, Ana C. Z.
    Cordeiro de Lima, Vladmir C.
    Freitas, Helano
    Werutsky, Gustavo
    Gaiger, Ana Maria
    Klock, Clovis
    Viola, Patricia P.
    Shiang, Christina
    de Macedo, Mariana P.
    Lopes, Lisandro F.
    De Marchi, Pedro
    Albino da Silva, Eduardo Caetano
    Moura, Fernando
    Borges, Giuliano
    Zaffaroni, Facundo
    Nunes Filho, Paulo Ricardo
    Araujo, Luiz H.
    Mascarenhas, Eldsamira
    Mathias, Clarissa
    Barrios, Carlos
    Zukin, Mauro
    CLINICAL LUNG CANCER, 2020, 21 (06) : E511 - E515
12345